Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer

Bibliographic Details
Title: Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer
Authors: den Uil, Sjoerd H., de Wit, Meike, Slebos, Robbert J.C., Delis-van Diemen, Pien M., Sanders, Joyce, Piersma, Sander R., Pham, Thang V., Coupé, Veerle M.H., Bril, Herman, Stockmann, Hein B.A.C., Jimenez, Connie R., Meijer, Gerrit A., Fijneman, Remond J.A.
Source: In European Journal of Cancer February 2021 144:91-100
Database: ScienceDirect
More Details
ISSN:09598049
DOI:10.1016/j.ejca.2020.10.029
Published in:European Journal of Cancer
Language:English